Status:
TERMINATED
Leukocyte Dysfunction in Diabetic Patients.
Lead Sponsor:
Sashwati Roy
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
40-60 years
Brief Summary
The purpose of this study is to study impairment of white blood cell function in patients with type II diabetes.
Detailed Description
Leucocytes from poorly controlled diabetes exhibit aberrant chemotaxis, increased susceptibility to bacterial infection, leukotriene production, lysosomal enzyme release, proinflammatory cytokine expr...
Eligibility Criteria
Inclusion
- Adults ages 40-60 yrs old clinically diagnosed with Type II Diabetes
- Adults ages 40-60 yrs old without Diabetes
Exclusion
- Unable to provide informed consent
- Pregnant Females
- Therapeutically Immuno-compromised
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01144520
Start Date
March 1 2010
End Date
December 1 2018
Last Update
November 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Wound Center
Columbus, Ohio, United States, 43221